Margaret Ancona's Insider Trades & SAST Disclosures
Margaret Ancona's most recent trade in Myriad Genetics, Inc. was a trade of 1,904 Common Stock done at an average price of $10.0 . Disclosure was reported to the exchange on March 22, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Margaret Ancona.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Myriad Genetics, Inc. | Margaret Ancona | SVP, Chief of Staff | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.01 per share. | 22 Mar 2025 | 1,904 | 128,684 (0%) | 0% | 10.0 | 19,059 | Common Stock |
| Myriad Genetics, Inc. | Margaret Ancona | SVP, Chief of Staff | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.01 per share. | 22 Mar 2025 | 718 | 130,588 (0%) | 0% | 10.0 | 7,187 | Common Stock |
| Myriad Genetics, Inc. | Margaret Ancona | SVP, Chief of Staff | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 54,124 | 136,295 (0%) | 0% | 0 | Common Stock | |
| Myriad Genetics, Inc. | Margaret Ancona | SVP, Chief of Staff | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.07 per share. | 13 Mar 2025 | 3,417 | 132,878 (0%) | 0% | 10.1 | 34,409 | Common Stock |
| Myriad Genetics, Inc. | Margaret Ancona | SVP, Chief of Staff | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.07 per share. | 13 Mar 2025 | 1,572 | 131,306 (0%) | 0% | 10.1 | 15,830 | Common Stock |
| Myriad Genetics, Inc. | Margaret Ancona | SVP, Chief of Staff | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.74 per share. | 25 Feb 2025 | 2,697 | 75,703 (0%) | 0% | 11.7 | 31,663 | Common Stock |
| Myriad Genetics, Inc. | Margaret Ancona | SVP, Chief of Staff | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2025 | 6,468 | 82,171 (0%) | 0% | 0 | Common Stock | |
| Myriad Genetics, Inc. | Margaret Ancona | SVP, Chief of Staff | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.64 per share. | 21 Sep 2024 | 966 | 78,400 (0%) | 0% | 27.6 | 26,700 | Common Stock |
| Myriad Genetics, Inc. | Margaret Ancona | SVP, Chief of Staff | Sale of securities on an exchange or to another person at price $ 27.82 per share. | 21 Aug 2024 | 11,538 | 79,366 (0%) | 0% | 27.8 | 320,987 | Common Stock |
| Myriad Genetics, Inc. | Margaret Ancona | SVP, Chief of Staff | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.24 per share. | 22 Mar 2024 | 730 | 90,904 (0%) | 0% | 22.2 | 16,235 | Common Stock |
| Myriad Genetics, Inc. | Margaret Ancona | SVP, Chief of Staff | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2024 | 35,178 | 93,219 (0%) | 0% | 0 | Common Stock | |
| Myriad Genetics, Inc. | Margaret Ancona | SVP, Chief of Staff | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.16 per share. | 14 Mar 2024 | 1,585 | 91,634 (0%) | 0% | 21.2 | 33,539 | Common Stock |
| Myriad Genetics, Inc. | Margaret Ancona | SVP, Chief of Staff | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.72 per share. | 25 Feb 2024 | 2,231 | 58,041 (0%) | 0% | 22.7 | 50,688 | Common Stock |
| Myriad Genetics, Inc. | Margaret Ancona | SVP, Chief of Staff | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.91 per share. | 22 Mar 2023 | 751 | 50,272 (0%) | 0% | 22.9 | 17,205 | Common Stock |
| Myriad Genetics, Inc. | Margaret Ancona | SVP, Chief of Staff | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 16,419 | 51,023 (0%) | 0% | 0 | Common Stock | |
| Myriad Genetics, Inc. | Margaret Ancona | SVP, Chief of Staff | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.54 per share. | 25 Feb 2023 | 2,556 | 34,604 (0%) | 0% | 18.5 | 47,388 | Common Stock |
| Myriad Genetics, Inc. | Margaret Ancona | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Mar 2022 | 9,754 | 37,160 (0%) | 0% | 0 | Common Stock | |
| Myriad Genetics, Inc. | Margaret Ancona | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.69 per share. | 25 Feb 2022 | 2,594 | 27,406 (0%) | 0% | 24.7 | 64,046 | Common Stock |
| Myriad Genetics, Inc. | Margaret Ancona | SVP Enterprise Transformation | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 30,000 | 30,000 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges